Table 3.
Summary of the CNVs identified
| CNVs | AF | PAF | VUS | PNAF | NAF | |
|---|---|---|---|---|---|---|
| SUD | 1.4% (8/587) | 1/8 | 2/8 | 4/8 | 1/8 | 0/8 |
| SUD/SIDS | 4.3% (1/23) | 0/1 | 0/1 | 1/1 | 0/1 | 0/1 |
| HCM | 1.2% (7/591) | 4/7 | 0/7 | 3/7 | 0/7 | 0/7 |
| DCM | 4.4% (6/136) | 3/6 | 0/6 | 2/6 | 1/6 | 0/6 |
| AC | 5.1% (6/118) | 2/6 | 3/6 | 1/6 | 0/6 | 0/6 |
| LVNC | 3.4% (1/29) | 0/1 | 0/1 | 1/1 | 0/1 | 0/1 |
| BrS | 1.3% (2/151) | 0/2 | 0/2 | 2/2 | 0/2 | 0/2 |
| LQTS | 4.7% (6/127) | 4/6 | 1/6 | 1/6 | 0/6 | 0/6 |
| SQTS | 0% (0/7) | – | – | – | – | – |
| CPVT | 0% (0/19) | – | – | – | – | – |
AC arrhythmogenic cardiomyopathy, AF affects function, BrS Brugada syndrome, CPVT catecholaminergic polymorphic ventricular tachycardia, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, LQTS long QT syndrome, LVNC left ventricular non-compaction, NAF does not affect function, PAF probably affects function, PNAF probably does not affect function, SIDS sudden infant death syndrome, SUD sudden unexplained death, VUS variant of unknown significance